Related references
Note: Only part of the references are listed.Combination of fluvastatin with pegylated interferon/ribavirin therapy reduces viral relapse in chronic hepatitis C infected with HCV genotype 1b
Masanori Atsukawa et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
An open-label randomized controlled study of pegylated interferon/ribavirin combination therapy for chronic hepatitis C with versus without fluvastatin
C. Kondo et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Alteration of Hepatic Nuclear Receptor-Mediated Signaling Pathways in Hepatitis C Virus Patients With and Without a History of Alcohol Drinking
Chuanghong Wu et al.
HEPATOLOGY (2011)
Boceprevir for Chronic HCV Genotype 1 Infection
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Serum Cholesterol and Statin Use Predict Virological Response to Peginterferon and Ribavirin Therapy
Stephen A. Harrison et al.
HEPATOLOGY (2010)
Hepatitis C Infection and Metabolic Syndrome
Ching-Sheng Hsu et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2010)
Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial
Edward J. Gane et al.
LANCET (2010)
Association of Lipid Profiles With Hepatitis C Viral Load in Chronic Hepatitis C Patients With Genotype 1 or 2 Infection
Ching-Sheng Hsu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Diagnosis, Management, and Treatment of Hepatitis C: An Update
Marc G. Ghany et al.
HEPATOLOGY (2009)
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
David L. Thomas et al.
NATURE (2009)
Clinical trial:: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alfa-2a plus ribavirin
V. G. Bain et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: A follow-up study in Taiwan
Chi-Ling Chen et al.
GASTROENTEROLOGY (2008)
Metabolic profiles in patients with chronic hepatitis C: a case-control study
Ching-Sheng Hsu et al.
HEPATOLOGY INTERNATIONAL (2008)
The lipid droplet is an important organelle for hepatitis C virus production
Yusuke Miyanari et al.
NATURE CELL BIOLOGY (2007)
被撤回的出版物: Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress (Retracted article. See vol. 94, 2020)
Gularn Waris et al.
JOURNAL OF VIROLOGY (2007)
Treatment of chronic hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alpha
Mitchell L. Shiffman et al.
HEPATOLOGY (2007)
Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins
Hua Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C
RP Myers et al.
JOURNAL OF VIRAL HEPATITIS (2003)
Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion:: a model of viral-related steatosis
G Perlemuter et al.
FASEB JOURNAL (2002)
Share Paper
